Status:
COMPLETED
The Associations of Microribonucleic Acid Gene Polymorphisms With the Risk of Ulcerative Colitis
Lead Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Conditions:
Colitis, Ulcerative
Eligibility:
All Genders
18-70 years
Brief Summary
From January 2020 to December 2024, diagnosed ulcerative colitis(UC) patients and gender- and age-matched normal controls were enrolled from the Department of Gastroenterology, the Second Affiliated H...
Detailed Description
From January 2020 to December 2024, diagnosed UC patients and gender- and age-matched normal controls were enrolled from the Department of Gastroenterology, the Second Affiliated Hospital of Wenzhou M...
Eligibility Criteria
Inclusion
- diagnosed UC based on comprehensive clinical, colonoscopy, histopathological, laboratory, and radiographic examination results
Exclusion
- rheumatoid arthritis, systemic lupus erythematosus, intestinal tuberculosis, ischemic enteritis, radiation enteritis, tumors, etc.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
926 Patients enrolled
Trial Details
Trial ID
NCT06873711
Start Date
January 1 2020
End Date
December 31 2024
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China